I-Tenofovir Alafenamide Hemifumarate TAF CAS 1392275-56-7 API Factory Anti-HIV High Quality
I-Tenofovir Commercial Related Intermediate:
I-Tenofovir CAS: 147127-20-6
I-Tenofovir Disoproxil Fumarate CAS 202138-50-9
I-Tenofovir Alafenamide Hemifumarate CAS 1392275-56-7
I-Chloromethyl Isopropyl Carbonate CAS 35180-01-9
I-Diethyl (p-Toluenesulfonyloxymethyl)phosphonate CAS 31618-90-3
(R)-(+)-Propylene Carbonate CAS 16606-55-6
(R)-9-(2-Hydroxypropyl)adenine CAS 14047-28-0
I-Diethyl (Hydroxymethyl)phosphonate CAS 3084-40-0
I-Adenine CAS 73-24-5
Igama Lekhemikhali | I-Tenofovir Alafenamide Hemifumarate |
Omqondofana | I-TAF;I-GS-7340 Hemifumarate |
Inombolo ye-CAS | 1392275-56-7 |
Inombolo yeCAT | I-RF-API91 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu |
I-Molecular Formula | I-C25H33N6O9P |
Isisindo samangqamuzana | 592.55 |
Izinga Lokushisa Lesitoreji | Kuvalwe kokuthi Omile, Izinga lokushisa Legumbi |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Amakristalu Amhlophe kuya Kucishe Amhlophe noma I-Crystalline Powder |
Ukuncibilika | I-Soluble ku-Dimethylformamide, ne-Methanol;Incibilika Kancane Emanzini naku-THF;Incibilika Kancane ku-Acetonitrile futhi Ayincibiliki ku-Dichloromethane ne-Toluene |
Ukuhlonza A | I-spectra yokumuncwa kwe-IR kufanele ihambisane nereferensi |
Ukuhlonza B | Isikhathi sokugcinwa sesiqongo esikhulu sesixazululo sesampula ku-chromatogram yokunquma okuqukethwe sihambisana naleso sesixazululo sereferensi. |
Ukuhlonza C | Isikhathi sokugcinwa kwe-Fumaric Acid senani eliphakeme le-chromatogram yokunquma okuqukethwe sivumelana nenani eliphakeme lesithenjwa |
Okuqukethwe kwamanzi (nge-KF) | ≤1.0% |
Ukucaca Kwesixazululo | Ngokuyisisekelo azikho izinhlayiya ezibonakalayo ku-2% (w/v) yokucaciswa kweMethanol Solution |
I-Residual Solvent | |
I-acetonitrile | ≤410ppm |
I-Ethanol | ≤5000ppm |
I-Dichloromethane | ≤600ppm |
I-Toluene | ≤890ppm |
Izinsalela ekushiseni | ≤0.10% |
Izinsimbi Ezisindayo | ≤20ppm |
Izinto Ezihlobene | |
I-PMPA | ≤1.0% |
I-PMPA Anhydride | ≤0.75% |
I-Phenyl PMPA eyodwa | ≤1.0% |
Noma Ikuphi Ukungcola Okungashiwongo | ≤0.15% |
Ukungcola Okuphelele | ≤2.0% |
Isomer | ≤1.0% |
Okuqukethwe kwe-Fumaric Acid | 9.0%~13.0% (kwisisekelo esingenamanzi) |
Imikhawulo yeMicrobial | |
Isamba se-Aerobic Microbial Count | ≤1000CFU/g |
Isamba Semvubelo Nesikhunta Sibala | ≤100CFU/g |
Escherichia Coli | Akekho |
Isivivinyo | 98.0%~102.0% (ngesisekelo se-anhydrous ne-solvent-free) |
Izinga Lokuhlola | I-Enterprise Standard |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Tenofovir Alafenamide Hemifumarate (TAF, GS-7340 hemifumarate), CAS 1392275-56-7, iyi-nucleotide reverse transcriptase inhibitor (NRTIs) kanye ne-prodrug yenoveli ye-Tenofovir (TFV).Ngokuvimbela i-reverse transcriptase, i-TAF ivimbela i-HIV ekuphindaphindeni futhi inganciphisa inani le-HIV emzimbeni.I-Tenofovir alafenamide iyisidakamizwa, okusho ukuthi isidakamizwa esingasebenzi.Emzimbeni, i-tenofovir alafenamide iguqulelwa ku-Tenofovir diphosphate (TFV-DP).I-Tenofovir Alafenamide Fumarate yagunyazwa ngoNovemba 2015 yokwelashwa kwe-HIV-1.